NUVB vs. AMPX
NUVB (Nuvation Bio Inc.) and AMPX (Amprius Technologies Inc.) are both stocks. NUVB operates in Biotechnology (Healthcare), while AMPX operates in Electrical Equipment & Parts (Industrials). Over the past 3 years, NUVB returned 49.62%/yr vs 9.36%/yr for AMPX. Their 0.18 correlation means their historical movements had little consistent relationship.
Performance
NUVB vs. AMPX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NUVB achieves a -29.35% return, which is significantly lower than AMPX's 21.67% return.
NUVB
- 1D
- -5.52%
- 1M
- 11.05%
- 6M
- 20.80%
- YTD
- -29.35%
- 1Y
- 183.86%
- 3Y*
- 49.62%
- 5Y*
- -6.03%
- 10Y*
- —
- ALL TIME*
- -7.42%
AMPX
- 1D
- 1.37%
- 1M
- -22.46%
- 6M
- -22.83%
- YTD
- 21.67%
- 1Y
- 50.94%
- 3Y*
- 9.36%
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- 1.65%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $51.41M | $65.22M | $125.73M | |
| $42.85M | $39.41M | $35.93M |
NUVB vs. AMPX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
NUVB Nuvation Bio Inc. | -29.35% | 236.84% | 76.16% | -21.35% | -23.51% |
AMPX Amprius Technologies Inc. | 21.67% | 181.79% | -47.07% | -33.29% | -11.99% |
Correlation
The correlation between NUVB and AMPX is 0.17, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.17 |
Correlation (3Y) Balances recent behavior with more history. | 0.19 |
Correlation (All Time) Calculated using the full available price history since Sep 15, 2022 | 0.18 |
Fundamentals
NUVB:
$2.20B
AMPX:
$1.36B
NUVB:
-$0.41
AMPX:
-$0.30
NUVB:
15.70
AMPX:
14.03
NUVB:
7.48
AMPX:
12.02
NUVB:
$143.05M
AMPX:
$90.26M
NUVB:
$131.08M
AMPX:
$16.37M
NUVB:
-$139.03M
AMPX:
-$17.72M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NUVB vs. AMPX — Risk / Return Rank
NUVB
AMPX
NUVB vs. AMPX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Nuvation Bio Inc. (NUVB) and Amprius Technologies Inc. (AMPX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NUVB | AMPX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.56 | ||
| Sortino ratioReturn per unit of downside risk | +1.44 | ||
| Omega ratioGain probability vs. loss probability | 1.37 | 1.14 | +0.22 |
| Calmar ratioReturn relative to maximum drawdown | 2.94 | 0.61 | +2.33 |
| Martin ratioReturn relative to average drawdown | 4.90 | 1.50 | +3.40 |
Loading charts...
Drawdowns
NUVB vs. AMPX - Drawdown Comparison
The maximum NUVB drawdown since its inception was -93.39%, roughly equal to the maximum AMPX drawdown of -94.49%. Use the drawdown chart below to compare losses from any high point for NUVB and AMPX.
Loading charts...
Drawdown Indicators
| NUVB | AMPX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -93.39% | -94.49% | +1.10% |
Max Drawdown (1Y)Largest decline over 1 year | -57.55% | -63.16% | +5.61% |
Max Drawdown (3Y)Largest decline over 3 years | -58.19% | -89.85% | +31.66% |
Max Drawdown (5Y)Largest decline over 5 years | -90.41% | — | — |
Current DrawdownCurrent decline from peak | -56.55% | -58.10% | +1.55% |
Average DrawdownAverage peak-to-trough decline | -65.32% | -54.70% | -10.62% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 34.48% | 25.68% | +8.80% |
Volatility
NUVB vs. AMPX - Volatility Comparison
The current volatility for Nuvation Bio Inc. (NUVB) is 15.45%, while Amprius Technologies Inc. (AMPX) has a volatility of 28.32%. This indicates that NUVB experiences smaller price fluctuations and is considered to be less risky than AMPX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NUVB | AMPX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.45% | 28.32% | -12.87% |
Volatility (6M)Calculated over the trailing 6-month period | 50.10% | 81.25% | -31.15% |
Volatility (1Y)Calculated over the trailing 1-year period | 87.89% | 106.81% | -18.92% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 75.67% | 127.82% | -52.15% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 72.87% | 127.82% | -54.95% |
Dividends
NUVB vs. AMPX - Dividend Comparison
Neither NUVB nor AMPX has paid dividends to shareholders.
Financials
NUVB vs. AMPX - Financials Comparison
This section allows you to compare key financial metrics between Nuvation Bio Inc. and Amprius Technologies Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
NUVB vs. AMPX - Profitability Comparison
NUVB - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Nuvation Bio Inc. reported a gross profit of 77.61M and revenue of 83.23M. Therefore, the gross margin over that period was 93.3%.
AMPX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Amprius Technologies Inc. reported a gross profit of 5.74M and revenue of 28.54M. Therefore, the gross margin over that period was 20.1%.
NUVB - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Nuvation Bio Inc. reported an operating income of 3.88M and revenue of 83.23M, resulting in an operating margin of 4.7%.
AMPX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Amprius Technologies Inc. reported an operating income of -6.69M and revenue of 28.54M, resulting in an operating margin of -23.4%.
NUVB - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Nuvation Bio Inc. reported a net income of 5.40M and revenue of 83.23M, resulting in a net margin of 6.5%.
AMPX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Amprius Technologies Inc. reported a net income of -5.05M and revenue of 28.54M, resulting in a net margin of -17.7%.
Frequently Asked Questions
NUVB and AMPX have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AMPX has higher volatility (28.32%) compared to NUVB (15.45%). In terms of maximum drawdown, NUVB dropped -93.39% vs AMPX's -94.49%.
NUVB currently has the higher Sharpe Ratio (1.93 vs 0.36), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NUVB and AMPX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer